Continuous Measurement of Diaphragm Excursion as a Predictor of Extubation

Status Completed

Clinical Trial Summary

Background: Patients are put under invasive mechanical ventilation (MV) during respiratory failure because they can no longer breathe in a way that delivers enough oxygen to their body. MV involves placing a tube into the wind pipe that is attached to a machine (known as a ventilator) which helps the patient breathe. However, MV is associated with complications such as shrinkage and damage of the diaphragm muscle fibres. It has been shown that the diaphragm (the main breathing muscle which provides approximately 70% of the work in healthy persons) can be affected after only 3-4 days of MV. Disconnection from the ventilator (a process known as extubation) is conducted with the calculated risk that the patient may become exhausted due to the additional workload of breathing off the ventilator resulting in needing to be reconnected to the ventilator (a process known as reintubation). Reintubation requires additional deep sedation of the patient and leads to longer time connected to the ventilator, increased risk of new lung infections, prolonged stay in the intensive care unit (ICU) and further immobilisation. Thus, the intensive care physician must constantly evaluate the need for MV to maintain adequate breathing versus withdrawal as quickly as possible to reduce the risk associated with long-term use of MV. However, to date, there is no technique for continuous assessment of diaphragm function that can be easily used at the patient's bedside. RESPINOR DXT, which offers continuous ultrasound monitoring of the right diaphragm velocity without the need of the continued presence of an operator, could offer an interesting solution. Aim: The primary objective of this study is to compare diaphragm excursion values obtained around a 30-minute SBT using RESPINOR DXT in patients who are successfully and unsuccessfully extubated. Data analysis will be performed using post-processing. The timepoints to be analysed will be: - Pre-SBT: 10, 30 and 60 minutes before the start of the SBT - During the 30-minute SBT: 0, 1, 2, 3, 4, 10, 20 and 30 minutes - Post-SBT: 5, 10, 20, 30 minutes, 1, 2, 3, 4, 6, 8, 12, 24, 48 hours after the end of the 30-minute SBT. Hypothesis: The investigators hypothesise that there will be significantly different median diaphragm excursion between successful and failed extubation groups in at least one of the timepoints of interest. The information from this pilot study will be used to design a fully-powered observational study. Primary outcome: Median diaphragm excursion

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Respiration, Artificial

Clinical Trial Details

NCT number	NCT03896048
Study type	Observational
Source	Respinor AS
Contact
Status	Completed
Phase
Start date	March 25, 2019
Completion date	October 13, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04107467` - Mechanical Ventilation Epidemiology in Argentina.
Recruiting	`NCT03181620` - Sedation Administration Timing: Intermittent Dosing Reduces Time to Extubation	N/A
Recruiting	`NCT03941002` - Continuous Evaluation of Diaphragm Function	N/A
Recruiting	`NCT03697785` - Weaning Algorithm for Mechanical VEntilation	N/A
Recruiting	`NCT05459116` - Visualization of Inspiratory Effort and Respiratory Mechanics to Promote Lung- and Diaphragm Protective Ventilation	N/A
Completed	`NCT01170156` - Fluid Leakage Past Tracheal Tube Cuff : Effect of Suctioning Manoeuvre	N/A
Recruiting	`NCT05141396` - Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)	N/A
Completed	`NCT04512677` - Ventilatory Weaning Guided by a New Index	N/A
Withdrawn	`NCT00536445` - Use of NAVA in Intubated Preterm	Phase 1/Phase 2
Completed	`NCT00097630` - ABC Trial: Awakening and Breathing Controlled	N/A
Recruiting	`NCT04602182` - Effectiveness of Musicotherapy in Weaning From Mechanical Ventilation	N/A
Recruiting	`NCT06120660` - Musical Intervention on Stress Effects in Critically Ill Patients	N/A
Active, not recruiting	`NCT04023643` - Pediatric Ventilation Weaning	N/A
Recruiting	`NCT03684291` - Hemodynamic Effects of Ventilation Modes
Recruiting	`NCT06195475` - Association Between Tidal Volume and Mortality in Pressure Support in Adults Under Invasive Mechanical Ventilation
Completed	`NCT05254691` - WOB and Paediatric Mechanical Ventilation	N/A
Terminated	`NCT00790725` - Proportional Assist Ventilation vs Pressure Support Ventilation	N/A
Completed	`NCT00638339` - Effects Of Invasive And Noninvasive Mechanical Ventilation On Sleep In The Intensive Care Unit (ICU)
Not yet recruiting	`NCT03255356` - Ventilation in Cardiac Surgery	N/A
Completed	`NCT01155648` - Pressure Support During Chest Wall Compression	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Continuous Measurement of Diaphragm Excursion as a Predictor of Extubation Failure

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms